In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Prognostic Factors for Acute Ischemic Stroke Patients with and without Neurosurgical Endovascular Intervention

    Final Number:
    313

    Authors:
    Benjamin M. Zussman BS; Adam Olszewski; Naomi Sell; Jill Galvao; Elisabeth Colacino RN; Mitchell Gil Maltenfort PhD; Stavropoula I. Tjoumakaris MD; Aaron S. Dumont MD; Robert H. Rosenwasser MD, FACS, FAHA; Pascal Jabbour MD; L. Fernando Gonzalez MD

    Study Design:
    Other

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2012 Annual Meeting

    Introduction: Baseline NIHSS score and time window (duration since ictus) are meaningful prognostic factors for acute ischemic stroke (AIS) patients treated with IV-tPA, but their value for patients treated with neurosurgical endovascular interventions is less well defined.

    Methods: IRB-approved retrospective review of prospectively-collected data for all patients that presented to a single comprehensive Stroke Center (SC) from January 1 to December 31, 2011, with AIS. Intervention was defined as successful/attempted endovascular neuro-thrombolysis/thrombectomy with intraarterial pharmacological and/or mechanical agents performed at SC. Patient parameters included NIHSS at presentation to SC (PreNIHSS), and duration from symptom onset until CT/CTA/CTP scanning (TimetoCT) and intervention (TimetoTX). Clinical outcome parameters included NIHSS at hospital discharge (DcNIHSS), duration of in-hospital stay from presentation to SC until discharge (LOS), modified Rankin Scale score at >=90 days (mRS), and PreNIHSS minus DcNIHSS (DeltaNIHSS). We used multivariate regression and Spearman's correlation to analyze factors affecting clinical outcome, and recursive partitioning to identify an algorithm predictive of large DeltaNIHSS for patients with intervention.

    Results: There were 344 patients with AIS and 64 (19%) had intervention. PreNIHSS was associated with clinical outcome for patients with and without intervention (Table 1, Figure 1). TimetoCT was not associated with clinical outcome for patients with and without intervention (Table 1), and TimetoTX was not associated with clinical outcome for patients with intervention (Table 2). For patients that had intervention, PreNIHSS > 12.5 and TimetoCT < 4.5 hours or between 5.5 and 7.5 hours predicted approximately 10 point DeltaNIHSS (Figure 2). Recursive partitioning-predicted DeltaNIHSS correlated with actual DeltaNIHSS (Spearman’s rho=0.62, p<0.001).

    Conclusions: Lower baseline NIHSS scores predict better clinical outcomes in AIS patients with and without neuroendovascular intervention. Time window is not an independent predictor of clinical outcome. In patients with high baseline NIHSS scores, the therapeutic time window for neuroendovascular intervention may be quite broad.

    Patient Care: This research further clarifies the role of baseline NIHSS score and time window, two popular data points within the stroke reperfusion literature, for patients with and without neuroendovascular intervention. Knowledge of meaningful prognostic factors will better inform clinical decision-making, which will improve patient care.

    Learning Objectives: By the conclusion of this session participants should be able to: (1) Describe the prognostic value of baseline NIHSS score in acute ischemic stroke patients with and without neuroendovascular intervention; and (2) Appreciate the role of time window on clinical outcome for acute ischemic stroke patients.

    References: (1) Abou-Chebl A: Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients. Stroke 41:1996-2000, 2010 (2) Arnold M, Schroth G, Nedeltchev K, Loher T, Remonda L, Stepper F, et al: Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion. Stroke 33:1828-1833, 2002 (3) Del Zoppo GJ, Saver JL, Jauch EC, Adams HP,Jr, American Heart Association Stroke Council: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: A science advisory from the american heart Association/American stroke association. Stroke 40:2945-2948, 2009 (4) Hussein HM, Georgiadis AL, Vazquez G, Miley JT, Memon MZ, Mohammad YM, et al: Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: A multicenter study. AJNR Am J Neuroradiol 31:454-458, 2010 (5) Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA, et al: Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 73:1066-1072, 2009

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy